Oasis Management Company’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Hold |
1,118,935
| – | – | 1.41% | 7 |
|
|
2025
Q1 | $9.99M | Buy |
1,118,935
+3,170
| +0.3% | +$28.3K | 1.9% | 11 |
|
|
2024
Q4 | $10.5M | Hold |
1,115,765
| – | – | 2.22% | 9 |
|
|
2024
Q3 | $8.99M | Sell |
1,115,765
-42,200
| -4% | -$340K | 1.94% | 10 |
|
|
2024
Q2 | $9.82M | Hold |
1,157,965
| – | – | 2.21% | 8 |
|
|
2024
Q1 | $10.4M | Buy |
1,157,965
+151,107
| +15% | +$1.36M | 3.07% | 6 |
|
|
2023
Q4 | $11.3M | Buy |
1,006,858
+53,604
| +6% | +$603K | 2.08% | 7 |
|
|
2023
Q3 | $8.23M | Buy |
953,254
+306,981
| +48% | +$2.65M | 0.36% | 11 |
|
|
2023
Q2 | $6.69M | Buy |
646,273
+23,997
| +4% | +$248K | 1.82% | 14 |
|
|
2023
Q1 | $6.75M | Buy |
622,276
+325,316
| +110% | +$3.53M | 1.08% | 18 |
|
|
2022
Q4 | $3.33M | Hold |
296,960
| – | – | 0.66% | 22 |
|
|
2022
Q3 | $3.01M | Buy |
+296,960
| New | +$3.01M | 0.51% | 30 |
|